ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Lexicon Pharmaceuticals (LXRX) Technical (Analysis) Reports Lexicon Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Lexicon Pharmaceuticals (LXRX)

Technical Analysis Report for NASDAQ stock LXRX Lexicon Pharmaceuticals. Dated: 18 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock LXRX Lexicon Pharmaceuticals then click here. or read Experts views on Lexicon Pharmaceuticals or Forecast & share price targets of Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Opened at 1.15 and Closed at: 1.17, which is 2.56% of previous session's close. It moved within a range of 1.14 and 1.25
The session was a Bullish session with an average volume of 1771598, which is -15.03% of previous session's volumes.

  • Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.

Support for tomorrow is 1.16 and resistance for tomorrow is 1.27
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.12, 1.08 resistance for tomorrow's hourly charts is 1.23, 1.3

10 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.28 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.33 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Lexicon Pharmaceuticals (LXRX) is 1.39 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 1.29 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Lexicon Pharmaceuticals is 0.99 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Lexicon Pharmaceuticals is at 1.33 and 200 DMA is at 0.99, while 50 DMA and 100 DMA are at 1.39 and 1.29 respectively

Lexicon Pharmaceuticals (LXRX) moving average of 20 SMA is at 1.33 and 20 EMA is at 1.31

Lexicon Pharmaceuticals (LXRX) moving average of 50 SMA is at 1.39 and 50 EMA is at 1.32

Lexicon Pharmaceuticals (LXRX) moving average of 100 SMA is at 1.29 and 100 EMA is at 1.22

Lexicon Pharmaceuticals (LXRX) moving average of 200 SMA is at 0.99 and 200 EMA is at 1.07

Tonix Pharmaceuticals has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Tonix Pharmaceuticals, about 27.79% more returns!

Lexicon Pharmaceuticals has performed better than Pulmatrix Inc in short term. Holding Lexicon Pharmaceuticals could be a better choice for now!

Prothena Corporation has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Prothena Corporation, about 4.69% more returns!

Moderna Inc has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Moderna Inc, about 49.82% more returns!

Alphatec Holdings has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Alphatec Holdings, about 12.69% more returns!

Atricure Inc has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Atricure Inc, about 32.86% more returns!

Capricor Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 371.64% more returns!

Compugen has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Compugen, about 10.7% more returns!

Edap Tms has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Edap Tms, about 29.16% more returns!

Fate Therapeutics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Fate Therapeutics, about 16.36% more returns!

Fulgent Genetics has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Fulgent Genetics, about 8.86% more returns!

Geron Corporation has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Geron Corporation, about 34.09% more returns!

Grifols S has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Grifols S, about 17.17% more returns!

Henry Schein has performed better than Lexicon Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 19.56% more returns!

Lexicon Pharmaceuticals Technical analysis of indicators

Price action analysis of Lexicon Pharmaceuticals (LXRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Lexicon Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Lexicon Pharmaceuticals in short term and the sell signal is strong.

Lexicon Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Lexicon Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Lexicon Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.27 and Lexicon Pharmaceuticals LXRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Lexicon Pharmaceuticals LXRX stock. Volume based technical analysis of Lexicon Pharmaceuticals LXRX stock is negative.

Lexicon Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock LXRX Lexicon Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And LXRX Experts View which covers a lot of information including buying and selling signals

LXRX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Lexicon Pharmaceuticals or View Candle Stick Charts here

Chart Lexicon Pharmaceuticals (LXRX)  Technical (Analysis) Reports Lexicon Pharmaceuticals [

Videos related to: Lexicon Pharmaceuticals (LXRX) Technical (Analysis) Reports Lexicon Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Lexicon Pharmaceuticals (LXRX)  Technical (Analysis) Reports Lexicon Pharmaceuticals [

 

Back to top